IP Library › Assignment 031571/0794
Patent Assignment
Reel/Frame 031571/0794

Assignment of Assignor's Interest

Recorded: 2013-11-08 Pages: 4
Assignor
RECRO PHARMA, INC.
Executed: 2013-10-23
Assignee
MALVERN CONSULTING GROUP, INC.
490 LAPP ROAD, MALVERN, PENNSYLVANIA, 19355
Covered Properties (2)
Topical Transdermal Dexmedetomidine Compositions and Methods of Use Thereof
Application: 13/520,959 →
Publication: US 2013/0072532
Intranasal Dexmedetomidine Compositions and Methods of Use Thereof
Patent: 9,795,559 →
Application: 13/711,407 →
Publication: US 2013/0178465
Related Assignments (12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 3, 2012
From: HENWOOD, GERALDINE A.; MACK, RANDALL J.; SHARR, CHRISTOPHER T.; KOLENG, JOHN J., JR.
To: RECRO PHARMA, INC.
Reel/Frame 029392/0378 →
Assignment of Assignor's Interest Oct 16, 2013
From: HENWOOD, GERALDINE A.; MACK, RANDALL J.; KOLENG, JOHN JOSEPH, JR.; SHARR, CHRISTOPHER T.
To: RECRO PHARMA, INC.
Reel/Frame 031415/0268 →
Assignment of Assignor's Interest Nov 8, 2013
From: RECRO PHARMA, INC.
To: MALVERN CONSULTING GROUP, INC.
Reel/Frame 031571/0731 →
Corrective Assignment to Correct the Assignor and Assignee Information and Remove the Additional Property Previously Recorded on Reel 031571 Frame 0794. Assignor(S) Hereby Confirms the Correct Assignor Is Malvern Consulting Group, Inc. and the Correct Assignee Is Recro Pharma, Inc. Nov 12, 2013
From: MALVERN CONSULTING GROUP, INC.
To: RECRO PHARMA, INC.
Reel/Frame 031626/0634 →
Corrective Assignment to Correct the Assignor and Assignee Information Previously Recorded on Reel 031571 Frame 0731. Assignor(S) Hereby Confirms the Correct Assignor Is Malvern Consulting Group, Inc. and the Correct Assignee Is Recro Pharma, Inc.. Nov 12, 2013
From: MALVERN CONSULTING GROUP, INC.
To: RECRO PHARMA, INC.
Reel/Frame 031626/0586 →
Security Interest Apr 14, 2015
From: RECRO PHARMA, INC.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 035403/0197 →
Security Interest Nov 17, 2017
From: RECRO PHARMA, INC.
To: ATHYRIUM OPPORTUNITIES III ACQUSITION LP
Reel/Frame 044166/0008 →
Release of Security Interest Nov 17, 2017
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: RECRO PHARMA, INC.
Reel/Frame 044481/0907 →
Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 044166 Frame: 0008. Assignor(S) Hereby Confirms the Security Interest. Mar 8, 2019
From: RECRO PHARMA, INC.
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 048540/0415 →
Assignment of Assignor's Interest Jan 30, 2020
From: RECRO PHARMA, INC.
To: BAUDAX BIO, INC.
Reel/Frame 051671/0536 →
Security Interest Jun 10, 2020
From: BAUDAX BIO N.A. LLC; BAUDAX BIO LIMITED; BAUDAX BIO, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 052891/0590 →
Release of Security Interest Dec 16, 2022
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
To: SOCIETAL CDMO, INC.
Reel/Frame 062123/0184 →